- Home
- JYD vs MIRA Comparison
JYD vs MIRA Comparison
Compare JYD & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JYD
- MIRA
- Stock Information
- Founded
- JYD 2001
- MIRA 2020
- Country
- JYD China
- MIRA United States
- Employees
- JYD N/A
- MIRA N/A
- Industry
- JYD Oil Refining/Marketing
- MIRA Biotechnology: Pharmaceutical Preparations
- Sector
- JYD Consumer Discretionary
- MIRA Health Care
- Exchange
- JYD Nasdaq
- MIRA Nasdaq
- Market Cap
- JYD 23.3M
- MIRA 20.5M
- IPO Year
- JYD 2023
- MIRA 2023
- Fundamental
- Price
- JYD $0.22
- MIRA $1.22
- Analyst Decision
- JYD
- MIRA Strong Buy
- Analyst Count
- JYD 0
- MIRA 2
- Target Price
- JYD N/A
- MIRA $14.00
- AVG Volume (30 Days)
- JYD 28.3M
- MIRA 3.4M
- Earning Date
- JYD 05-20-2025
- MIRA 05-20-2025
- Dividend Yield
- JYD N/A
- MIRA N/A
- EPS Growth
- JYD N/A
- MIRA N/A
- EPS
- JYD N/A
- MIRA N/A
- Revenue
- JYD $77,444,271.00
- MIRA N/A
- Revenue This Year
- JYD N/A
- MIRA N/A
- Revenue Next Year
- JYD N/A
- MIRA N/A
- P/E Ratio
- JYD N/A
- MIRA N/A
- Revenue Growth
- JYD 13.54
- MIRA N/A
- 52 Week Low
- JYD $0.09
- MIRA $0.51
- 52 Week High
- JYD $8.00
- MIRA $5.01
- Technical
- Relative Strength Index (RSI)
- JYD 31.94
- MIRA 62.38
- Support Level
- JYD $0.19
- MIRA $1.03
- Resistance Level
- JYD $0.22
- MIRA $1.30
- Average True Range (ATR)
- JYD 0.04
- MIRA 0.11
- MACD
- JYD 0.14
- MIRA 0.03
- Stochastic Oscillator
- JYD 55.74
- MIRA 82.61
About JYD Jayud Global Logistics Limited
Jayud Global Logistics Ltd is a end-to-end supply chain solution providers in China, with a focus on providing cross-border logistics services. It offers freight forwarding services, (ii) supply chain management, and (iii) other value-added services.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.